Cargando…
Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD)
AIM: Apply a recently developed expert elicitation procedure to evaluate the state of the current knowledge of the two brominated flame retardants (BFRs) most commonly used today; decabromo-diphenyl ether (decaBDE) and hexabromocyclododecane (HBCD) and their potential impact on human health in order...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388476/ https://www.ncbi.nlm.nih.gov/pubmed/22759507 http://dx.doi.org/10.1186/1476-069X-11-S1-S7 |
_version_ | 1782237198173601792 |
---|---|
author | Ravnum, Solveig Zimmer, Karin E Keune, Hans Gutleb, Arno C Murk, Albertinka J Koppe, Janna G Magnanti, Brooke Lyche, Jan L Eriksen, Gunnar S Ropstad, Erik Skaare, Janneche U Kobernus, Michael Yang, Aileen Bartonova, Alena Krayer von Krauss, Martin |
author_facet | Ravnum, Solveig Zimmer, Karin E Keune, Hans Gutleb, Arno C Murk, Albertinka J Koppe, Janna G Magnanti, Brooke Lyche, Jan L Eriksen, Gunnar S Ropstad, Erik Skaare, Janneche U Kobernus, Michael Yang, Aileen Bartonova, Alena Krayer von Krauss, Martin |
author_sort | Ravnum, Solveig |
collection | PubMed |
description | AIM: Apply a recently developed expert elicitation procedure to evaluate the state of the current knowledge of the two brominated flame retardants (BFRs) most commonly used today; decabromo-diphenyl ether (decaBDE) and hexabromocyclododecane (HBCD) and their potential impact on human health in order to support policy considerations. This expert elicitation was organized by the HENVINET (Health and Environment Network) Consortium. METHOD: The HENVINET expert elicitation procedure that was used in the evaluations of decaBDE and HBCD is a rapid assessment tool aimed at highlighting areas of agreement and areas of disagreement on knowledge-related key issues for environment and health policy decision making. RESULTS: The outcome of the expert consultation on BFRs was concrete expert advice for policy makers with specific priorities for further action made clear for both stakeholders and policy makers. The experts were not in agreement whether or not the knowledge currently available on decaBDE or HBCD is sufficient to justify policy actions, but most experts considered that enough data already exists to support a ban or restriction on the use of these compounds. All experts agreed on the necessity of more research on the compounds. Priority issues for further research were, among others: • more studies on the extent of human exposure to the compounds. • more studies on the fate and concentration in the human body of the compounds. |
format | Online Article Text |
id | pubmed-3388476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33884762012-07-03 Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) Ravnum, Solveig Zimmer, Karin E Keune, Hans Gutleb, Arno C Murk, Albertinka J Koppe, Janna G Magnanti, Brooke Lyche, Jan L Eriksen, Gunnar S Ropstad, Erik Skaare, Janneche U Kobernus, Michael Yang, Aileen Bartonova, Alena Krayer von Krauss, Martin Environ Health Methodology AIM: Apply a recently developed expert elicitation procedure to evaluate the state of the current knowledge of the two brominated flame retardants (BFRs) most commonly used today; decabromo-diphenyl ether (decaBDE) and hexabromocyclododecane (HBCD) and their potential impact on human health in order to support policy considerations. This expert elicitation was organized by the HENVINET (Health and Environment Network) Consortium. METHOD: The HENVINET expert elicitation procedure that was used in the evaluations of decaBDE and HBCD is a rapid assessment tool aimed at highlighting areas of agreement and areas of disagreement on knowledge-related key issues for environment and health policy decision making. RESULTS: The outcome of the expert consultation on BFRs was concrete expert advice for policy makers with specific priorities for further action made clear for both stakeholders and policy makers. The experts were not in agreement whether or not the knowledge currently available on decaBDE or HBCD is sufficient to justify policy actions, but most experts considered that enough data already exists to support a ban or restriction on the use of these compounds. All experts agreed on the necessity of more research on the compounds. Priority issues for further research were, among others: • more studies on the extent of human exposure to the compounds. • more studies on the fate and concentration in the human body of the compounds. BioMed Central 2012-06-28 /pmc/articles/PMC3388476/ /pubmed/22759507 http://dx.doi.org/10.1186/1476-069X-11-S1-S7 Text en Copyright ©2012 Ravnum et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Ravnum, Solveig Zimmer, Karin E Keune, Hans Gutleb, Arno C Murk, Albertinka J Koppe, Janna G Magnanti, Brooke Lyche, Jan L Eriksen, Gunnar S Ropstad, Erik Skaare, Janneche U Kobernus, Michael Yang, Aileen Bartonova, Alena Krayer von Krauss, Martin Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title | Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title_full | Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title_fullStr | Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title_full_unstemmed | Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title_short | Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD) |
title_sort | policy relevant results from an expert elicitation on the human health risks of decabromodiphenyl ether (decabde) and hexabromocyclododecane (hbcd) |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388476/ https://www.ncbi.nlm.nih.gov/pubmed/22759507 http://dx.doi.org/10.1186/1476-069X-11-S1-S7 |
work_keys_str_mv | AT ravnumsolveig policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT zimmerkarine policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT keunehans policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT gutlebarnoc policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT murkalbertinkaj policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT koppejannag policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT magnantibrooke policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT lychejanl policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT eriksengunnars policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT ropstaderik policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT skaarejannecheu policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT kobernusmichael policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT yangaileen policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT bartonovaalena policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd AT krayervonkraussmartin policyrelevantresultsfromanexpertelicitationonthehumanhealthrisksofdecabromodiphenyletherdecabdeandhexabromocyclododecanehbcd |